Evidence map›Paper›PMID 35551962›Full record

Trial reportJournal of the American Academy of Dermatology2023

Secukinumab improves mild-to-moderate psoriasis: A randomized, placebo-controlled exploratory clinical trial.

Jaehwan Kim, Jongmi Lee, Jason E Hawkes, Xuan Li, Norma Kunjravia, Darshna Rambhia, Inna Cueto, Ariana Moreno, Hong Hur, Sandra Garcet and 3 more

Abstract readRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Journal of the American Academy of Dermatology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Jaehwan KimLaboratory for Investigative Dermatology, The Rockefeller University, New York, New York; Department of Dermatology, University of California, Davis, Sacramento, California; Dermatology Section, Veterans Affairs Northern California Health Care System, Mather, California. Electronic address: derkim@ucdavis.edu.
Jongmi LeeLaboratory for Investigative Dermatology, The Rockefeller University, New York, New York.
Jason E HawkesDepartment of Dermatology, University of California, Davis, Sacramento, California.
Xuan LiLaboratory for Investigative Dermatology, The Rockefeller University, New York, New York.
Norma KunjraviaLaboratory for Investigative Dermatology, The Rockefeller University, New York, New York.
Darshna RambhiaLaboratory for Investigative Dermatology, The Rockefeller University, New York, New York.
Inna CuetoLaboratory for Investigative Dermatology, The Rockefeller University, New York, New York.
Ariana MorenoLaboratory for Investigative Dermatology, The Rockefeller University, New York, New York.
Hong HurResearch Bioinformatics, Center for Clinical and Translational Science, The Rockefeller University, New York, New York.
Sandra GarcetResearch Bioinformatics, Center for Clinical and Translational Science, The Rockefeller University, New York, New York.
Wei ZhouLaboratory of Single-cell Genomics and Population Dynamics, The Rockefeller University, New York, New York.
Junyue CaoLaboratory of Single-cell Genomics and Population Dynamics, The Rockefeller University, New York, New York.
James G KruegerLaboratory for Investigative Dermatology, The Rockefeller University, New York, New York. Electronic address: jgk@rockefeller.edu.

Funding

Developing, Demonstrating, and Disseminating Innovative Programs to Achieve Translational SuccessUL1TR001866 · NCATS · ROCKEFELLER UNIVERSITY · PI COLLER, BARRY, KRUEGER, JAMES G · 2016 to 2025
$40.6M
NCATS NIH HHS UL1 TR001866
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antibodies, Monoclonal, HumanizedPsoriasisDouble-Blind MethodHumansSeverity of Illness IndexTreatment OutcomeAntibodies, Monoclonal, Humanizedsecukinumabdendritic cellsgene expressionIL-17mild-to-moderate diseasepsoriasissecukinumabT cellstype 17 T cells

Identifiers

PMID35551962
PMCPMC11314355

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.